Tower Research Capital LLC (Trc) Statera Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.08 - $0.23 $78 - $225
-979 Reduced 3.16%
29,967 $2,000
Q3 2022

Nov 10, 2022
BUY
$0.13 - $0.28 $926 - $1,995
7,125 Added 29.91%
30,946 $4,000
Q2 2022

Aug 15, 2022
BUY
$0.21 - $0.38 $5,002 - $9,051
23,821 New
23,821 $7,000
Q4 2021

Feb 14, 2022
SELL
$2.01 - $4.08 $27,920 - $56,675
-13,891 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$2.29 - $6.24 $31,810 - $86,679
13,891 New
13,891 $32,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email